Skip to main content

Unbiased. Straight Facts.TM

Ozempic label now notes potential side effect of intestinal blockage

The U.S. Food and Drug Administration (FDA) updated the label for Ozempic, a type 2 diabetes drug that is often used for weight loss, to now note the potential side effect of intestinal blockage.

Media Miss by the Right

See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below.

Learn more about this data

Left 13%

Center 88%

Right 0%

Bias Distribution

Click to see headlines

Far
Left

+0

Left

+0

Lean
Right

+0

Right

+0

Far
Right

+0

37 other sources covering this story

Total News Sources

37

Leaning Left

4

Center

28

Leaning Right

0

Last Updated

5 months ago

Bias Distribution Powered by Ground NewsTM

By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.